CAS |
No.77307-50-7 |
英文名称 |
SL 0101-1 |
分子式 |
C25H24O12 |
分子量 |
516.45 |
溶解性 |
Soluble in --- |
纯度 |
≥98% |
外观(性状) |
Light yellow to yellow Solid |
储存条件 |
Powder: 2-8℃,2 years |
运输条件 |
冷藏运输 |
MDL |
MFCD09842349 |
SMILES |
OC1=CC(O)=C(C(C(O[C@@H]2O[C@@H](C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]2O)=C(C3=CC=C(O)C=C3)O4)=O)C4=C1 |
InChIKey |
SXOZSDJHGMAEGZ-IGKKHSBFSA-N |
InChI |
InChI=1S/C25H24O12/c1-10-21(34-11(2)26)24(35-12(3)27)20(32)25(33-10)37-23-19(31)18-16(30)8-15(29)9-17(18)36-22(23)13-4-6-14(28)7-5-13/h4-10,20-21,24-25,28-30,32H,1-3H3/t10-,20+,21-,24-,25-/m0/s1 |
PubChem CID |
10459196 |
靶点 |
Ribosomal S6 Kinase (RSK) |
通路 |
MAPK |
背景说明 |
SL 0101-1是选择性的、可逆的、ATP竞争性的 p90核糖体S6激酶(RSK) 的抑制剂。 |
生物活性 |
SL 0101-1 (SL0101), a kaempferol glycoside, isolated from the tropical plant F. refracta, is a cell-permeable, selective, reversible, ATP-competitive p90 Ribosomal S6 Kinase (RSK) inhibitor, with an IC50 of 89 nM[1]. SL 0101-1 (SL0101) is a selective RSK1/2 inhibitor, with a Ki of 1 μM[2]. |
IC50 |
RSK1 |
In Vitro |
SL 0101-1 (SL0101) shows proliferation inhibition in human breast cancer cell line MCF-7 and produces a cell cycle block in G1 phase[1]. |
数据来源文献 |
[1]. Smith JA, et al. Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. Cancer Res. 2005 Feb 1;65(3):1027-34. [2]. Yu Li, et al. The Affinity of RSK for Cylitol Analogues of SL0101 Is Critically Dependent on the B-ring C-4'-hydroxy. Chem Commun (Camb). 2020 Mar 10;56(20):3058-3060. |
规格 |
1mg 5mg |
单位 |
瓶 |